Biopharmaceutics & drug disposition - JoVE Visualize

Showing results (1301-1310 of 2,132) with videos related to

Pageof 214

Sort By:

Biopharmaceutics & Drug Disposition|November 1, 1993

An estimate of the rate of direct drug diffusion from the surface of heart and kidney--implications for their representation as compartmentsY F Huang, R N Upton

Biopharmaceutics & Drug Disposition|March 1, 1993

Plasma concentrations and hemodynamic effects of intravenous, sublingual, and aerosolized nitroglycerin in patients undergoing cardiac catheterizationS H Curry, L M Lopez, C R Lambert, et al.

Biopharmaceutics & Drug Disposition|March 1, 1993

Bioavailability and disposition kinetics of HI-6 in Beagle dogsJ D Baggot, A Buckpitt, D Johnson, et al.

Biopharmaceutics & Drug Disposition|January 1, 1993

Pharmacokinetics and bioavailabilities of hymecromone in human volunteersE R Garrett, J Venitz, K Eberst, et al.

Biopharmaceutics & Drug Disposition|May 1, 1996

Glucuronidation of diflunisal, (-)-morphine, 4-nitrophenol, and propofol in liver microsomes of two patients with Crigler-Najjar syndrome type IF M Brunelle, A A Raoof, J de ville de Goyet, et al.

Biopharmaceutics & Drug Disposition|November 1, 1995

Pharmacokinetic parameters of antipyrine in dog after hepatectomyM Galtier, D Briand, F Pinguet, et al.

Biopharmaceutics & Drug Disposition|November 1, 1995

The effect of aging on the pharmacokinetics of nalbuphine in rabbitsS T Ho, J J Wang, O Y Hu, et al.

Biopharmaceutics & Drug Disposition|July 1, 1995

Pharmacokinetics of the antiarrhythmic agent tiracizine: steady state kinetics in comparison with single-dose kineticsA Berndt, R Oertel, B Terhaag, et al.

Biopharmaceutics & Drug Disposition|April 1, 1993

Pharmacokinetic study of a tripeptide HIV-1 protease inhibitor, KNI-174, in rats after intravenous and intraduodenal administrationsA Kiriyama, T Mimoto, Y Kiso, et al.

Biopharmaceutics & Drug Disposition|February 12, 2004

Rapid determination method of caffeine and application to monitoring of caffeine-assisted chemotherapyMasami Kawahara, Hiromi Kagiyama, Yoshimitsu Kanazawa, et al.

Pageof 214

Showing results (1301-1310 of 2,132) with videos related to

Sort By:

Pageof 214

Biopharmaceutics & Drug Disposition|November 1, 1993

An estimate of the rate of direct drug diffusion from the surface of heart and kidney--implications for their representation as compartmentsY F Huang, R N Upton

Biopharmaceutics & Drug Disposition|March 1, 1993

Plasma concentrations and hemodynamic effects of intravenous, sublingual, and aerosolized nitroglycerin in patients undergoing cardiac catheterizationS H Curry, L M Lopez, C R Lambert, et al.

Biopharmaceutics & Drug Disposition|March 1, 1993

Bioavailability and disposition kinetics of HI-6 in Beagle dogsJ D Baggot, A Buckpitt, D Johnson, et al.

Biopharmaceutics & Drug Disposition|January 1, 1993

Pharmacokinetics and bioavailabilities of hymecromone in human volunteersE R Garrett, J Venitz, K Eberst, et al.

Biopharmaceutics & Drug Disposition|May 1, 1996

Glucuronidation of diflunisal, (-)-morphine, 4-nitrophenol, and propofol in liver microsomes of two patients with Crigler-Najjar syndrome type IF M Brunelle, A A Raoof, J de ville de Goyet, et al.

Biopharmaceutics & Drug Disposition|November 1, 1995

Pharmacokinetic parameters of antipyrine in dog after hepatectomyM Galtier, D Briand, F Pinguet, et al.

Biopharmaceutics & Drug Disposition|November 1, 1995

The effect of aging on the pharmacokinetics of nalbuphine in rabbitsS T Ho, J J Wang, O Y Hu, et al.

Biopharmaceutics & Drug Disposition|July 1, 1995

Pharmacokinetics of the antiarrhythmic agent tiracizine: steady state kinetics in comparison with single-dose kineticsA Berndt, R Oertel, B Terhaag, et al.

Biopharmaceutics & Drug Disposition|April 1, 1993

Pharmacokinetic study of a tripeptide HIV-1 protease inhibitor, KNI-174, in rats after intravenous and intraduodenal administrationsA Kiriyama, T Mimoto, Y Kiso, et al.

Biopharmaceutics & Drug Disposition|February 12, 2004

Rapid determination method of caffeine and application to monitoring of caffeine-assisted chemotherapyMasami Kawahara, Hiromi Kagiyama, Yoshimitsu Kanazawa, et al.

Pageof 214